Safety Issues Raised in Key Trial Supporting Rivaroxaban Use

Share this content:
Safety Issues Raised in Key Trial Supporting Rivaroxaban Use
Safety Issues Raised in Key Trial Supporting Rivaroxaban Use

THURSDAY, Feb. 4, 2016 (HealthDay News) -- Use of a faulty device in a regulatory drug trial has raised questions relating to rivaroxaban use, according to a feature article published online Feb. 3 in The BMJ.

Deborah Cohen, associate editor from The BMJ, discusses the defective point-of-care device used in one arm of a trial examining use of rivaroxaban to prevent ischemic stroke in non-valvular atrial fibrillation. The companies involved relied on a single trial, ROCKET AF, to gain approval for rivaroxaban from regulators in Europe and the United States.

Cohen notes that concerns have been expressed about these results, with suggestions that care for the warfarin control arm patients in the trial may have been compromised. The point-of-care device used to measure international normalized ratio in patients taking warfarin was recalled in December 2014, as some devices delivered results that were "clinically significantly lower" than a laboratory method; the fault went back to 2002, before the start of the ROCKET AF trial. This could result in an unnecessary increase in warfarin dose, potentially leading to increased risk of bleeding, and questioning the validity of the results.

"The study should be considered of uncertain validity until a more thorough review can be done," Harlan Krumholz, M.D., from Yale University in New Haven., Conn., said in the article, adding that there should be "an investigation by an independent group of experts to quickly determine if there are grounds for retraction."

Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Study Provides Estimates of U.S. Prevalence of Type 1, 2 Diabetes

Study Provides Estimates of U.S. Prevalence of Type ...

Prevalence of type 1 diabetes 0.5 percent, type 2 diabetes 8.5 percent among U.S. adults

Black Individuals at Highest Risk of Legal Intervention Injury

Black Individuals at Highest Risk of Legal Intervention ...

Increase in rates of injuries from 2005 to 2009, followed by a drop to 2015, returning to ~2005 levels

Research Links Doctor Burnout to Patient Safety Incidents

Research Links Doctor Burnout to Patient Safety Incidents

Physician burnout linked to increased risk of patient safety incidents, reduced patient satisfaction

is free, fast, and customized just for you!




Already a member?

Sign In Now »